PDCD1 and melanoma: In addition, the CXCR4 antagonist Peptide R54 potentiates the inhibition of cell-intrinsic PD-1, T cell-independent response, in human melanoma xenograft providing relevant information for combinatorial approaches to enhance antitumor immunity.